文献速递产科母胎医学

重度早产子痫前期:按种族比较结局

Severe preterm preeclampsia: an examination of outcomes by race.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-07-22

该回顾性队列研究纳入2008至2017年本院<34周重度早产子痫前期孕妇275例,比较黑人(184例)与非黑人(91例)的母儿结局。约74%接受期待治疗,两组无差异;期待治疗者复合母体发病率30.5%,校正混杂后种族间无差异(aOR 1.02,95%CI 0.97-1.35)。

要点

  • 重度早产子痫前期期待治疗率约74%,黑人与非黑人无差异(P=.6)。
  • 期待治疗者复合母体发病率30.5%,种族间无差异(P=.5)。
  • 校正年龄、BMI、产次后aOR 1.02(95%CI 0.97-1.35),新生儿发病率无差异。

核心结论

  • 在本研究人群中,接受期待治疗的重度早产子痫前期黑人与非黑人孕妇的母体结局无差异。

研究设计与样本

  • 回顾性队列研究,纳入2008至2017年本院<34周重度早产子痫前期孕妇275例,黑人184例(67%),非黑人91例(33%)。

主要发现

  • 203/275例(约74%)接受期待治疗,非黑人75.8% vs 黑人72.8%,P=.6。
  • 期待治疗者中62例(30.5%)发生复合母体发病率,非黑人27.5% vs 黑人32.1%,P=.5。
  • 校正母亲年龄、体重指数和产次后,调整比值比1.02(95%CI 0.97-1.35)。
  • 诊断至分娩的中位潜伏期为3天,两组无差异(P=.9)。
  • 新生儿复合发病率非黑人60.9% vs 黑人53%,P=.3。

关键数值与推荐

  • 重度早产子痫前期定义依据当时美国妇产科医师学会(ACOG)指南。
  • 主要结局为复合母体发病率:溶血、肝酶升高和低血小板计数;子痫;肺水肿;严重肾功能不全;胎盘早剥;母体重症监护室入住;静脉血栓栓塞;输血;子宫切除;卒中;或死亡(≥1项)。

临床怎么用

  • 对于<34周重度早产子痫前期,黑人孕妇接受期待治疗时母体结局与非黑人相似。
  • 种族间母体发病率差异可能源于产前管理之外的因素,需进一步研究。

局限性

  • 单中心回顾性队列研究,样本量275例,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia complicates 5% to 8% of all pregnancies. Previous studies have examined the maternal morbidity and mortality associated with preeclampsia and the expectant management of severe preterm preeclampsia. However, these studies either did not comment on outcomes by race or were primarily made up of nonblack participants. OBJECTIVE: This study aimed to determine whether maternal morbidity associated with the expectant management of severe preterm preeclampsia varied by race. STUDY DESIGN: We performed a retrospective cohort study of women with a diagnosis of severe preterm preeclampsia at <34 weeks' gestation between 2008 and 2017 at our institution. Severe preterm preeclampsia was defined by current American College of Obstetricians and Gynecologists guidelines. The primary outcome was a maternal morbidity composite, defined as experiencing ≥1 of the following: hemolysis, elevated liver enzymes, and low platelet count; eclampsia; pulmonary edema; severe renal dysfunction; abruption; maternal intensive care unit admission; venous thromboembolism; blood transfusion; hysterectomy; stroke; or death. Secondary outcomes included a composite of neonatal morbidity. Outcomes were compared between self-reported black and nonblack women. RESULTS: In this study, 275 women were included; among those women, 91 (33%) were nonblack, and 184 (67%) were black. In addition, 203 of 275 women (approximately 74%) underwent expectant management with no difference by race (75.8% of nonblack vs 72.8% of black women; P=.6). When examining maternal morbidity, 62 of the expectantly managed women (30.5%) developed the composite maternal morbidity outcome, with no difference by race (27.5% of nonblack vs 32.1% of black women; P=.5) even when adjusting for confounders such as maternal age, body mass index, and parity (adjusted odds ratio, 1.02; 95% confidence interval, 0.97-1.35). The median time from diagnosis to delivery (latency time) was 3 days, with no difference between the 2 groups (P=.9) and no difference in neonatal morbidity (60.9% nonblack vs 53% black; P=.3). CONCLUSION: Within our population, there were no differences in maternal outcomes between black and nonblack women who were undergoing expectant management of severe preterm preeclampsia. More research is needed to determine if the known disparities in maternal morbidity among races are due to factors beyond the antepartum management of severe preterm preeclampsia.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Peterson JA, Sandgren K, Levine LD, et al. Severe preterm preeclampsia: an examination of outcomes by race. Am J Obstet Gynecol MFM. 2020. PMID: 33345907. doi:10.1016/j.ajogmf.2020.100181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。